Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

write, "infectious disease experts say it's junk science, and worse, would risk doubling or tripling the number of Americans dead from COVID-19." Court Bars Census Bureau From Giving Administration Data On Migrants. In what the New York Times (10/22, Wines, 18.61M) describes as "a blow to President Trump's plan to up

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

y write, "infectious disease experts say it's junk science, and worse, would risk doubling or tripling the number of Americans dead from COVID-19." Court Bars Census Bureau From Giving Administration Data On Migrants. In what the New York Times <https://vvww.nytimes.corn/2020/10/22/us/elections/census-immigrant-trump.ht

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

write, "infectious disease experts say it's junk science, and worse, would risk doubling or tripling the number of Americans dead from COVID-19." Court Bars Census Bureau From Giving Administration Data On Migrants. In what the New York Times (10/22, Wines, 18.61M) describes as "a blow to President Trump's plan to up